Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
1151
CALL
People Inc
PPLI
$3.09B
| $39.4M | 0.01% |
681,521
-195,839
| -22% | -$8.7M |
|
1152
CF Industries
CF
$19.2B
| $39.3M | 0.01% |
1,397,584
+262,340
| +23% | +$7.46M |
|
1153
Lamar Advertising Co
LAMR
$16.2B
| $39.3M | 0.01% |
588,853
+263,623
| +81% | +$16.1M |
|
1154
Iovance Biotherapeutics
IOVA
$1.82B
| $39.3M | 0.01% |
1,431,325
+362,717
| +34% | +$11.9M |
|
1155
PUT
Gaotu Techedu
GOTU
$434M
| $39.3M | 0.01% |
654,800
+489,400
| +296% | +$19.4M |
|
1156
Knowles
KN
$3.13B
| $39.3M | 0.01% |
2,573,558
-85,888
| -3% | -$1.28M |
|
1157
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $39.2M | 0.01% |
412,495
+72,780
| +21% | +$6.7M |
|
1158
Natera
NTRA
$38.3B
| $39.1M | 0.01% |
785,203
+61,506
| +8% | +$2.47M |
|
|
VAR
1159
DELISTED
Varian Medical Systems, Inc.
VAR
| $39.1M | 0.01% |
319,462
+41,072
| +15% | +$4.76M |
|
1160
IPG Photonics
IPGP
$3.61B
| $39.1M | 0.01% |
243,989
+17,642
| +8% | +$2.51M |
|
1161
PUT
McDonald's
MCD
$192B
| $39.1M | 0.01% |
212,100
-27,400
| -11% | -$5.02M |
|
1162
CALL
Toll Brothers
TOL
$13.6B
| $39.1M | 0.01% |
1,200,000
+650,000
| +118% | +$17.8M |
|
1163
Griffon
GFF
$3.95B
| $39.1M | 0.01% |
2,109,673
+222,491
| +12% | +$3.62M |
|
|
HOLX
1164
DELISTED
Hologic
HOLX
| $39M | 0.01% |
683,628
-733,005
| -52% | -$36M |
|
1165
PUT
Applied Materials
AMAT
$403B
| $38.9M | 0.01% |
643,900
+35,700
| +6% | +$1.93M |
|
1166
Boyd Gaming
BYD
$6.18B
| $38.9M | 0.01% |
1,861,565
+1,243,647
| +201% | +$22.7M |
|
1167
Chesapeake Utilities
CPK
$3.19B
| $38.9M | 0.01% |
463,059
-143,871
| -24% | -$12.5M |
|
1168
Teva Pharmaceuticals
TEVA
$40.8B
| $38.8M | 0.01% |
3,147,807
+58,920
| +2% | +$666K |
|
1169
Home BancShares
HOMB
$6.23B
| $38.8M | 0.01% |
2,519,937
+530,841
| +27% | +$7.46M |
|
|
GBT
1170
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $38.7M | 0.01% |
613,654
-84,603
| -12% | -$5.8M |
|
|
DNKN
1171
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $38.7M | 0.01% |
593,436
-109,632
| -16% | -$6.82M |
|
1172
Nektar Therapeutics
NKTR
$2.39B
| $38.6M | 0.01% |
111,086
-9,844
| -8% | -$3.07M |
|
1173
PennyMac Financial
PFSI
$3.92B
| $38.6M | 0.01% |
923,117
+403,310
| +78% | +$12.8M |
|
1174
KeyCorp
KEY
$24.2B
| $38.6M | 0.01% |
3,166,028
-986,755
| -24% | -$11.5M |
|
1175
CALL
Salesforce
CRM
$151B
| $38.4M | 0.01% |
205,000
+6,900
| +3% | +$1.16M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.